Eperezolid

This classification denotes an antibiotic with the molecular formula C18H23FN4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C460ZSU1OW, chemically known as acetamide, n-((3-(3-fluoro-4-(4-(hydroxyacetyl)-1-piperazynyl)phenyl)- 2-oxo-5-oxazolidinyl)methyl)-, (s)- but generally known as eperezolid, which bears US NIH Compound Identifier 73214. European Medicines Agency schedules Eperezolid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06559MIG. The term EPEREZOLID is an International Non-Proprietary Name. EPEREZOLID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eperezolid under HS 29349990 and SITC 51579. As of Q4 2014, EPEREZOLID remains the US FDA Preferred Term for this commodity. Eperezolid bears US NLM identifiers UMLS ID C0663242 and NCI Concept Code C81444. SMILES: FC1C(N2CCN(CC2)C(=O)CO)CCC(N2CC(OC2=O)CNC(=O)C)C1.